LICENSE AGREEMENTLicense Agreement • March 28th, 2023 • PDS Biotechnology Corp • Pharmaceutical preparations • New York
THIS LICENSE AGREEMENT (the “Agreement”) is dated as of December 30, 2022 (the “Effective Date”) by and between Merck KGaA, a corporation with general partners organized under German law, having a place of business at Frankfurter Strasse 250, 64293 Darmstadt, Germany (“Licensor”) and PDS Biotechnology Corporation, a company incorporated under the laws of the State of Delaware, USA, having a place of business at 25B Vreeland Road, Suite 300, Florham Park, New Jersey 07932, USA (“Company”). Licensor and Company may be referred to herein as a “Party” or, collectively, as “Parties”.
